Zeynep Sena Agim added an answer:What is the best in-vitro parkinson's disease model?
Im trying to conduct a neuroprotective assay with SH-SY5Y cells differentiated with RA and TPA to dopaminergic neurons.
There seem to be multiple cell lines capable of similar feats, and some that seem to be used more without differentiation.
Is there any reason to go through the trouble of dual differentiation? or would it be easier and more reliable/reproducible to work with N2A/CATHa/PC12 cell lines, as they seem to be the standard in neuroprotective research.
I understand that SH-SY5Y cells are of human origin, but even still, they dont seem to be heavily used when compared to mouse line.
In our lab we are using SH-SY5Y cells for PD research. N27 rat dopaminergic cell line is another choice of ours. However, I think, one of the best options you can use is the primary midbrain cultures isolated from rat embryos. We dissect midbrain from E17 rat embryos and culture the cells. It's, obviously, a mixed culture including dopaminergic and GABAergic neurons, as well as astrocytes and microglia. You can also inhibit the growth of glial cells in cultures dishes via different treatments if you wanna eliminate these. Since it's a mixed culture, you can see the effect of your treatment/chemical/compound on different neuronal or glial cells, which might be an advantages depending on the purpose of your neuroprotective assay.
I hope this helps a bit. Good luck!Following
S. K Sharma added an answer:How can I store MPTP?
Does anyone know how to store MPTP? I just buy 10mg powder MPTP from SIGMA. And the product information says that the aqueous solutions may be stored for 24 hours at 4 ° C.
However, I need 0.1mg of it dissolved in 1 μl saline in each experiment. If I dissolve all the MPTP in saline at once, I am afraid after 24 hours the left MPTP can not be used any more.
So I wonder very much how to store MPTP, should I have to divide the powder MPTP into 100 pieces and dissolve it in 1 μl saline each time before each experiment?
Does anyone can help me, thank you very much!
Dear Dr. Hong,
I fully agree with the above researchers. The Parkinsonian Neurotoxin, 1-Methyl, 4-Phenyl, 1,2,3,6 Tetrahydropyridine (MPTP) is a Mepridine analog and belong to the category of Tetrahydro-isoquinolines.
In addition, I would like to keep MPTP in an amber container as it is photo-labile. So it will be good idea to make the serial or log dilutions in amber tubes.
It is hygroscopic also, So it will be better to store it in a dessicator with dehydrating silicon balls.
You will be using a face mask. a hood, and reconstitute the entire powder in saline directly by using 1 ml microsyringe with a needle and a vent. Please do not open the vial just mix the entire solution couple of times and then aliquot in micrioials.
I would also suggest you to please use cryo-vials if you need to store the reconstituted dilutions of MPTP at -30C or at -80C.
Avoid keeping the solution at room temp and under direct sunlight. As instructed above, use it as fresh as possible. Repeated freezing and thawing can cause chemical degradation of the product.
I hope it is helpful and universal for any other toxic substance as well.
Good luck with your research.
Sushil Sharma, Ph.D; D.M.R.I.T
Professor of Pharmacology &
Saint James School of Medicine
Plaza Juliana 4, Kralendijk
Bonaire, Dutch Caribbean
Varun Ahuja added an answer:Translational research: Does a toxic lesion of degenerative nature, which is not relevant to humans, become adverse if it results in proliferation?
Adversity and translatability to humans: 2. Is a toxic lesion of degenerative nature which is not relevant to humans starting to get translatable when preneoplastic lesions are formed (non-Reversible) ? And if this adverse event is not relevant to humans because it is not translatable to humans ? Question to be discussed: Should the term adverse only be used when a translatability to humans can not be ruled out ? In consequence should it be only used for cross species findings ?Following
Huong Ha added an answer:How to increase the frequency/amplitude of AMPAR mediated mini EPSCs in culture neurons?
I am interested in AMPAR mediated mini EPSCs in hippocampal neurons. My current recording configuration (hibernate E as bath solution and Cs gluconate as internal) seem to allow me to record from them up to day in vitro (DIV) 25 for about 30 min with fairly stable access. The sad story is that I do not see a lot of mini events (1 - 2 events every 3 - 5 seconds --> much less than 1 Hz). I can see quite a lot spontaneous events starting at DIV 11 already (1 - 2 event every second or so). Does it sound like something you experience before? How would you recommend troubleshooting it? Maybe, like, changing the recording condition or culture condition to have more mini AMPAR EPSCs? Thanks a lot!!!
Below are some more information if you would like to know....
When the neurons are younger (Div 12 - 15), there are a lot of action potential driven EPSCs [huge events, > 100 pA]. And when they get to Div 25, there are mostly very small events (20 pA, more or less). The small events decay time is approximately from 4 - 30 ms.
Regarding the culture, Coverslips are coated with 1 mg/ml Poly D lysine. I plate the neurons from E17 - E 18 hippocampi at 1.4 millions neurons per 100 mm dish containing 6 coverslips. The coverslips are submerged in serum containing media. The coverslips have wax feet so I can flip them up side down into 60 mm dishes with neurobasal + B27 + glutamax + 20 % media conditioned by astrocytes [which facilitates the growth of a lot of astrocytes underneath the neurons].
Sometimes I also co-culture the neuron coverslips in dishes with astrocyte feeder layers [in which the cells are not touching each other i.e. Banker culture]. The viability and development look fairly good. I can see a fairly dense network of dendrites already at DIv 11 and it just gets denser over time. Cells are evenly distributing across the coverslip, not much fasciculation or any sign of substrate problem. I feed them twice a week after the first week.
@Thomas: As always, many ideas! Thank you! :) It is very helpful indeed!
- Regarding your concern for LTD, I did not see any reduction of spon events within once cells. About 2 weeks ago, I recored from ~ 4 week old neurons (who were not co-cultured with astrocytes) and they did not have much of the big EPSCs. This week we started to have Banker cultured neurons at ~ 3 week old and these all seem to have very robust spontaneous EPSCs and look very nice (3D-looking, smooth membrane, nice processes).
- I have not analyzed the data but looks like these new neurons have higher mini frequency already (still lower than 1 Hz though). I might still need to heat them up or try your suggestion with the KCl to get more response and reduce recording time. Thank you for this!
- The density is about as high as we can do considering other factors. I tried higher density before but the media just got acidic so quickly and the neurons were not healthy...
-For your question about cortical and hippocampal neurons, no, they did not look like they had the same final density. The cortical neurons usually looked slightly denser than the hippocampal neurons even if we plated them at same density. I don't have any quantification on this yet though. This was mostly from my quick glance at the traces
@Saak: That is super insightful! I do use Cs gluconate as internal with all of the voltage clamp experiment but did not really think about the geography of culture processes that hard. :) From my staining experiments, culture neurons do have synapses everywhere, and their dendrites stretch quite far. I have not measured and compared these numbers to in vivo neurons. Would be interesting to learn more.
I did not know that culture neurons have mainly GABAergic synaptic activity... I saw quite a lot of mini-like activity (events <~ 20 pA, frequency is way higher than 1 Hz) when recording w/o drugs. And when I added APV, picrotoxin and TTX, the frequency of tthese is like... below 1 Hz. I was thinking the activity was mostly driven by AMPAR and NMDAR since I am holding the cells at -70 mV (close to Cl- reverse potential). Did not at all think of GABA... Did you do some measure with this?Following
Jochen F Staiger added an answer:How can we verify that our brain slice manages to preserve the thalamocortical pathway?
I just get very puzzled when reading some paper results about brain slice work, when the author stimulates one intracortical region and records the response of another intracortical region, how can I know whether it is direct connection between these two regions or may involve other subcortical regions, eg the thalamus? I didn't find any evidence in the paper about preserving the thalamocortical pathway or not. How can I understand the results in these kinds of paper?
Hope anybody expert in brain slice work can help me with this. Thanks
Tracing is necessary. An alternative to DiI is biocytin. See attached PDF.Following
Saak V. Ovsepian added an answer:How do I program P97 puller to make a glass recording electrode for brain slice hippocampus LTP?
How do I program P97 puller to make a glass recording electrode for LTP?
Dear Kaichuan, please follow simple steps below to get things going : (1) check the filament and make sure that it is installed properly; (2) run a ramp test - this is quite easy (just google for the details or check Sutter Instruments website); (3) use the readouts of ramp as your starting parameters for the filament and glass you have (4) adjust the temperature, delay and velocity until you will get electrodes with parameters you would like to use. Keep in mind that with higher temperature the tip of electrode becomes smaller, which increases the resistance. Typically, for field potentials electrodes should not exceed 3 mega Om, while for whole cell you need pipettes with higher resistance (up to 6-7 mega Om). Good luck -Following
Sumana Chakravarty added an answer:Does anyone have experience with in utero injections of mouse embryos?
I did in utero injection of 0.5 microliter of fast green with 26 g hamilton injector into cerebroventricular of 16 days mouse embryo, but it was born dead. I don't know why? What is falls? May it be due to infection or because injection into the brain? How could I do that?
Thanks Bruna. I will also try glass capillary next time. In fact, I do not sterilize the needle as we don't have multiple needles and once you do one animal again you have to do for next animal (I think it is impractical for my case)...so I take care of needle very carefully for not to touch anywhere during the process and in between animals I whip it by alcohol swab...wait to dry...then use it again. FYI, I use another clean needle/ syringe set for empty vector.
I will be happy if it works for you.Following
Graham Peter Michael Burnett added an answer:Why does music evoke emotions or feelings?Music has many bodily effects. This is not trivial.Following
Fatiha Chigr added an answer:How can I isolate choroid plexus from mouse brain?
As it is obvious, choroid plexus in mouse brain is very small and I am not sure that I can have enough quantity of it for RNA extraction.
Personnally I prefer to get CP from all ventricles. This gives more chance to perform your RNA extraction.Following
David J Hodson added an answer:Can someone recommend a neuronal tracer that diffuses in short time in fixed tissue?
I used DiI and I traced very well some fibers, but a disadvantage is that when it's exposed to UV light in a microscope, loses fluorescence very quickly. I need a tracer in fixed tissue because it's easier to administrate the tracer in the zone that I'm studying than in stereotaxic. Thanks.
Justin's answer pretty much covers everything. The only thing I would add is to maybe think about using multiphoton excitation if you continue to have issues. Dil can be excited at ~ 700 nm and this would significantly reduce photobleaching, as well as increase axial/lateral resolution due to the two-photon effect.Following
Saivishal Daripelli added an answer:Which region is best for implanting reference electrode for measuring theta oscillations in CA1? How can I get peak frequency of 7-8Hz in CA1 region?
I want to measure modulation of theta oscillation in CA1 (Hippocampus) region by stimulating NPO (Nucleus Pontis Oralis) in rats. I have gone through the literature where researchers used Frontal bone or ear bar or cerebellum as reference. Can anyone suggest me, which region is best for reference electrode to get synchronized theta waves?
In literature it was mentioned 0.5 to 3.0V current is required to get synchronized theta. But we are getting synchronized theta in CA1 (cerebellum as reference), only when we stimulate NPO by 3.0V and peak frequency was 4-5Hz. Is there any possibility to get peak frequency of 7-8Hz with low voltage stimulation?
Thanks Bali and Molden for your replies. My apologies for the delay in acknowledging the same.
Your suggestions are really helpful for us.
By using constant current (60 uA) for stimulation now we are able to get theta oscillations of 5-6Hz with cerebellar reference, but after Donepezil treatment we are observing decrease in amplitude of theta (which was reported to increase). What could be the reason for this?
Benjamin A Suter added an answer:Has anyone had problems with a channel rhodopsin AVV killing neurons?
I purchased the CamKIIa-ChR2-eYFP from the UNC vector core. This is the one from the Deisseroth lab.
My problem is that when we infected some rats with this virus and took fresh slices for electrophysiology (~5weeks post injection), it looked like almost all of the neurons at the injection site were dead under the infrared camera. There were still plenty eYFP positive projections, but almost no soma.
However, I also ran a second batch of adult animals at a separate time point. When I perfused rats 8 weeks post-AAV injection and slice/mount the fixed tissue, I can see very dense eYFP projections at the injection site (similar to what was seen with the fresh e-phys tissue). Oddly, the soma are completely devoid of eYFP (looks like dark holes in the tissue, figure attached), but that pattern looks similar to representative images I see in other publications. There is also still DAPI positive staining in the nuclei. I've been told that this is just the result of the ChR2-eYFP fusion protein moving into the terminals. This makes me think there wasn't much of a problem, at least in this batch. I've had mixed results running behavior with optogenetic stimulation.
Has anyone had a problem with cell death using AAV5-CamKII-ChR2-eYFP?
Did the injection volume vary between your animals, or between the two batches of surgeries? I've heard of people seeing vastly increased cell health at the injection site and increased axonal transfection at projection sites after reducing the volume of virus injected. While it likely depends on titer, a volume of ~30-50 nl per site seems appropriate in cortex for typical (e.g. UPenn) AAVs; not sure for your injection locations.
Regarding appearance of soma: with ChR2-fluorophore fusion proteins, I believe it's common to have a dim somatic signal since it's just in the membrane and not cytosolic, while the dendrites and axons may appear to have a more discernible signal.Following
Benjamin A Suter added an answer:Does anyone know the distance a certain optical light can diffuse in the brain issue?
Hi, I am trying to use optogenetics to study the connection of two nucleus within rat brain. However, the distance between this two nucleus is only 1mm. Does anyone know the distance a certain optical light can diffuse in the brain issue? Thanks!
Bottom line: if you're using a fiber, and place the tip ~200 um from the stimulation target (a common distance), your target will see only ~10% of the light intensity measured at the tip of the fiber.
Another useful source, that synthesizes from a number of publications:
This includes measurements by Svoboda's group that look at the lateral spread for an LED on the cortical surface.Following
Michael Alexander added an answer:Is chemotherapy-induced cognitive dysfunction in cancer survivors due to effects on microglia or endothelial cells?
If you are aware of the fact that cancer patients treated with standard chemotherapy over the past 20 or so years have cognitive problems with reasoning and motor skills, I'd like your input on why, and why ten to twenty years later. Microglia (brain macrophages, which is a misnomer) can initiate the process of neurodegeneration, which leads to ex-cancer patients, who've survived through chemotherapy, down the path of significant brain damage. There is an initial insult due to systemic inflammation, but I'm thinking that endothealial damage and their ability to secrete inflammatory lymphokines perpetuate or exhasterbate chemotherapy-induced cognitive problems in cancer patients.
What do you think?
Thank you Peter that was very helpful. This section of the book I'm writing has to do with surviving cancer and it's treatment. The book itself is an overview of how cancer changed our society. The book, like my others, is an effort to translate the information from the large variety disciplines involved with this societal change. It looks at both the 'Big Picture' and 'Detailed Picture' of cancer and society. I'm very thankful for the input from you as well as a myriad of other professionals in seemingly unrelated disciplines that have helped me put together this work.Following
Jennifer H Steel added an answer:Does anyone have an idea what can be the problem during our RNA ISH on free-floating mouse brain sections?
We do RNA ISH on formalin fixed mouse brain slices (not paraffin embedded or frozen)(40 µm) with DIG-labelled RNA riboprobes as described in the attached file.
The problem is that the success of the protocol is about 40%. Once we got sign, then there is no signal, even if the circumstances are almost the same. May be the duration of perfusion with DEPC treated PB(± 2 min) and PFA-fixed brain slicing differ time to time, could it cause significant mRNA degradation in the tissue?
The other possibility we thought is the degradation of the probes. We store them at -20°C and dilute during ISH as described in the protocol (in the attached file). What is the best way to check the integrity and functionality of the probes? Or could be something else the problem?
We started using this technique recently, so we have not so much experience in RNA ISH. We appreciate every help!
Do you have a positive control? All our ISH was controlled (on frozen or paraffin sections) using beta actin as a positive control probe, done on a separate section. This should tell you whether the RNA is well preserved. Then your specific target can be detected using your own probe on other sections. In my protocol, the anti-dig antibody is incubated at room temperature for 1 hour but the NBT-BCIP substrate detection is on overnight. Many probes, optimal dilution, require overnight NBT-BCIP. If the signal appears quickly it is often non-specific in my experience. Another consideration is the probe size and hybridisation temperature. I have always used 50°C overnight, for any probe longer than about 100 bp. Oligos can be hybridised at 37°C.Following
Alexander von Holst added an answer:What is the best way to enzymatically dissociate mouse brain tissue that gives a high yield for all cell types (neurons, astrocytes, microglia)?
We currently use mechanical dissociation, but our astrocyte yield is low. We've tried papain (I'm not sure which concentration we used), but it did not give a good yield for neurons. We want to minimize cell death during dissociation as well as maximize preservation of cell surface markers (e.g. CD11b). Any suggestions? Thanks!Following
Michael Alan Bozarth added an answer:Why is I.c.v. injection of vehicle solution affecting the performance of mice undergoing a fixed ratio 1 schedule of reinforcement?
I have a batch of C57BL/6J male mice (3 month/old) undergoing a fixed ratio 1 schedule of reinforcement (1h/day, 2 hrs after dark onset, 10% sucrose) with an implanted cannula into the later ventricle. They press the active lever 80-100 times, and the inactive lever 10-20 times. They are now really accustomed to the injection procedure since I did 7-10 days of sham injections, but every time I inject the vehicle solution (1ul in 3mins; I tried PBS, then saline and lastly aCSF) their performance drops at 30-40 concerning the active lever, and 0-5 concerning the inactive lever. I am running the sessions 2h following i.c.v. injection but before the session the mice already look "unwilling" and not really active. I also tried to inject them every day, but their performance stabilized at a low level (40-50 lever presses).
Any advise/suggestion is very welcome.
Many thanks in advance.
I haven't worked with mice, so please take any comments or suggestions I make here with the proverbial "grain of salt" (pun not intended but somewhat amusing anyway).
I would be suspicious of two things, both related to possible trauma caused by the injection procedure. First, make sure that the injection cannulae are placed properly within the ventricle. Remember that drug solutions flow up (not down) following a microinjection-- they follow the path of least resistance which is up the cannula shaft. It's possible that the injection is actually causing pressure/trauma to tissue directly above your cannula placement. Have your tired other A-P injections sites? (I'm presuming that you've already histologically confirmed your cannulae placements and checked for gross tissue damage in the surrounding area.)
Second, consider the injection speed. I understand that your intended infusion rate is acceptably slow, but is it in actuality? Movement of the PE or other flexible tubing typically used to connect the injection pump or other device to the injection cannua often leads to uncontrolled infusions. Have you checked for flow after removing your injection cannula? Simply making a subsequent injection into air should confirm that the system is working properly--if you don't see a nice, round, well-formed fluid 'bubble' on the end of your injection cannula after making a single injection 'into air' following the intended microinjection into the subject, you have inadvertently injected an uncontrollably large volume into your subject. I always made at least two subsequent 'air injections' that should appear to be about the same size (Although one obviously can't accurately visualize a one microliter volume, with experience it is fairly easy to tell if the volume appears to be correct; I typically used a 100 nl volume and learned to readily visual its approximate size in air. My microinjections tended to be very good or associated with an occasional problem, making this simple post-injection fluid-visualization test basically a 'go or no-go' evaluation of the probable microinjection accuracy.).
Finally, I published the design for a low-pressure injection device in the Journal of Neuroscience Methods around 1980 (sorry, but I don't have an electronic copy of this article). This device uses gas pressure which will compress when meeting significant tissue resistance thus infusing solution more at a rate readily acceptably by brain tissue. Histological examination revealed minimal tissue damage using this method when compared with traditional microinjection procedures.
(FYI: I developed this microinjection method [which I called EMIT -- electrolytic microinjection transducer] for my own work in intracranial self-administration [ICSA]. This experimental method places additional requirements on the contingency as well as the reliability of the microinfusions. I've also used this method successfully for microinjections delivered to subjects habituated to the test apparatus and for not disturbing them by picking them up and the necessary handling restraint while performing the injection procedure 15 minutes after connecting the device (e.g., Hamilton & Bozarth). I don't necessarily suggest that you change to this microinjection procedure because the EMIT system's proper construction and use usually requires some on-site training or other special care not documented adequately in the published literature [A commercial firm tried manufacturing EMIT units, but sloppy construction practices produced gas leaks which caused the system to malfunction; additionally, some special training or care is necessary when using this approach to delivering microinfusions.]. My laboratory has been closed for some time now, or I would invite you for a visit to Buffalo to learn more about the construction and use of this low-pressure microinjection system.]
Good luck with your continued research. Do take your time and care in setting-up your basic procedure so that you can be confident in your experimental outcomes. I've found that most people simply ignore the problems with conventional approaches to delivering reliable microinjections, relying on calculated estimates or watching a bubble move in the infusion line. Neither of these approaches are sufficient to ensure reliable microinjections. (FYI: I conducted a series of studies in the 1980s using radiolabelled drug and determining the actual amount delivered with conventional and with EMIT microinjection procedures. I found the EMIT system to reliably deliver even delayed infusions into freely moving subjects, while conventional microinjection approaches using a microinjection syringe and PE tubing to be totally unreliable. Unfortunately the full journal report was never submitted for publication and the work appeared only in a Society for Neuroscience Abstract (Mitchell and Bozarth) and presented at the corresponding annual meeting.)
I'm not sure I can (or will) find my way back to this posting, so if you have any questions you can contact me directly at: firstname.lastname@example.org.
P.S. I generally used unbuffered Ringer's solution without any problems, avoiding the debate over the proper composition of artificial CSF that was prevalent during my active research years. Also, although I think your one-microliter volume is fine, it might still present a problem with injections delivered inadvertently into tissue or delivered to rapidly. Nonetheless, I would probably stay with this volume to increase the likelihood of reliably delivering your intended drug dose into the ventricles (Of course, the volume would have to be MUCH smaller for tissue injections into a mouse brain.)Following
Hadil Alahdal added an answer:Does any one know a good IgG mouse anti nestin to stain neurons in brain sections?
I am using 40u free floating mouse brain sections.
That helped a lot.Following
Adriana Gisler added an answer:Does anyone know of a brain structure checklist (focus on frontal lobes) for a chicken embryo model?
I want to quantify gross brain morphology observations/deviations in a chicken embryo model, so that I can run an ANOVA, instead of doing it qualitatively.
Thank you in advance for your help.
That is very helpful, Matthew!! I will definitely look into the article. Also, I just ordered the atlas you just mentioned. Thanks again for your help.
Paul Legrand added an answer:Is the extrapyramidal syndrome associated with Midazolam Fentanyl sedation?
We recently had a extrapyramidal syndrome after a procedure under councious sedation. A Fentanyl Midazolam comination was used with 0.25mg of scopolamine. Has anyone some experience with the management of this problem?
Ondansetron was not given as there were no nausea problems. The EPS symptoms dissapered after 6 h. teh rest of the follow up was uneventful.Following
Pardis Td added an answer:What is the relationship between hyperprolactemia and mental illness?
i know that some antipsychotic medications can cause hyperprolactemia as a side effect, but I am wondering whether the dopamine and GABA imbalance produced by hyperprolactemia resulting say from a pituitary adenoma can cause serious mental impairment.Following
Tatyana Pivneva added an answer:Can we use TTC stained brain slices for any other purposes?
I am doing research on stroke animal models and generally use middle cerebral artery occlusion induced focal cerebral model. As you know the infarction degree is quantified by TTC staining and the brain slices are thrown after the photographing. I am suspecting that can we use the TTC stained brain section for other purpose such as protein extraction and western blot or RNA extraction etc. If you have any idea about it please let me know. Thanks in advance.
I only used TTC staining for a MCAO model of the insult .
Christian D Wilms added an answer:Which is the best dye for neuronal fast calcium transients?
We want to record the calcium transient uder a neuronal spike with patch-clamp associated with photomultiplier PMT. We want to perform this experiment in acute brain slice, with non permeant and non ratiometric dye. Which is the best dye for this kind of experiments?
I agree with Stefan that CaGreen dextrans are quite nice and give very good, lasting fills. For simply following the timing of [Ca2+] transients this would also be a good choice. But if you want to quantify the [Ca2+] any dextran will be a bad choice, as the conjugation reaction seriously distorts the affinity, leading to an indicator that contains a mix of different affinities, ranging over more than an order of magnitude. The affinity (= KD) reported on the vial is an average of this mix.Following
Alicja Binkowska added an answer:Do you have any knowledge of the effects of cannabis on pineal gland in human?
I have been reading a lot about cannabis and it's impact on human brain and body since quite long time. Now, the pineal gland is in the middle of my interest. I'm wondering if there are any effects of cannabis on pineal gland in human. I've found very poor info about that, if you know something more about that please share!
Thank you a lot for your answers, I'll check both suggestions!Following
Janet Mcalister added an answer:I need information on air freshener substances and their effects on the brain
i am looking for research materials on the effects of air freshener substances on the brain, i have seen some materials but they are not scientifically backed. i know some of the substances causes toxic encephalopathy, dementia and other neurological diseases but i need their scientific basis
This is a good overview of neurotoxicity from para-dichlorobenzene which is one of the most common chemicals added to air fresheners:
Carlo Condello added an answer:Who can name a lab or vendor which has experience with multiplexed immunofluorescence in preclinical animal models, especially with brain tissues?
GE offers their MultiOmyx methodology for multiplex IHC and imaging
Manuela Meireles added an answer:What is the difference between BV2 and N9 microglial cell lines?.Following
Marcia H. Ratner added an answer:Is there any research into the consequences of manipulating the normal progression of dementia by utilizing drugs such as Aricept or Namenda?
There is always cost to interrupting the normal function of the body. What are the consequences of manipulating the neuro system in delaying dementia?
At least one study has shown that higher cumulative anticholinergic use is associated with an increased risk for dementia.
see Gray et al., 2015
Marek Matejak added an answer:How do I convert concentration in mg/kg to physiological concentration?
I am looking for calculations to convert the concentration of crude compounds fed to animals (in mg/kg) to a physiological concentration (in M) for brain slices whole cell patch clamp experiments. Does anyone know how this calculation works?
Selected physical units:
'kg/kg' .. mass fraction of substance (mass of substance per mass of total mixture)
'kg' .. mass of substance
'mol' .. amount of substance (about 6x10^23 number of particles)
'mol/kg' .. molality (amount of substance per mass of total mixture)
'mol/L' .. molar concentration (amount of substance per volume of solution)
'L' .. volume of solution
'kg/L' .. density (volumetric mass density of total mixture)
'kg/mol' .. molecular weight (molar mass) of substance (can be estimated from weights of elements of periodic table, from which the molecules of substance are composed )
'M' is typically 'mol/L' the molar concentration (amount of substance per liter of solution). However some papers give it another meaning, so I recommend to use full notation as 'mol/L' to avoid missunderstandings.
It is a good practice to use these units as variables in equations. For example:
.. [kg/kg] / .. [kg/mol] = .. [mol/kg]
.. [mol/kg] * .. [kg/L] = .. [mol/L]Following
Touqeer Ahmed added an answer:Is a 2nd LTP induction on a similar brain slice valid for comparison?
NOTE: This is a continuation from a previous post regarding the issue of fEPSP depression upon induction of LTP. (https://www.researchgate.net/post/Why_is_fEPSP_depressed_upon_induction_of_LTP)
I have an additional query with regards to this issue of fEPSP depression.
Sometimes, a 1st attempt at LTP leads to immediate fEPSP depression. However after some time, the fEPSP returns back to baseline, and I redo the I-O and successfully manage to induce LTP on this 2nd attempt on the same slice. Is LTP valid in this instance?
In another scenario, I manage to induce LTP on the 1st attempt, but I wait until it falls back to baseline, then I repulsed the slice with HFS for a 2nd LTP induction, which similarly exhibits robust LTP (that drops gradually just like the 1st LTP). Is this 2nd LTP induction also valid for inclusion?
I am aware that LTP induction leads to the synthesis of plasticity-related proteins, hence, I have a hypothesis that it is easier to re-induce LTP on slices that have successfully had a 1st LTP.
Here are also some additional queries I hope to seek for your help in.
- Should the electrodes be placed within stratum radiatum or stratum moleculare (as both have Schaffer Collaterals) in CA1? I was also told that both the recording and stimulating electrode should be on the same Schaffer Collateral pathway (but there's no way to confirm for that visually when lowering the electrodes onto the slices isn't it?)
- What is the physiological mechanism behind this LTP induction-induced fEPSP 'depression'? Discussions with my lab mates suggest either stimulation of inhibitory interneurons or overstimulation of glutaminergic neurons, but I don't find them convincing.
- Has anyone compared how the use of Morris ACSF (for slice recordings) vs Sucrose ACSF (protective cutting method with supposed better preservation of neurons, used in my lab only for patch clamping brain slices) would affect their findings?
Second time LTP induction would not be a good idea to compare. The synaptic plasticity related genes are expressed and the magnitude between the respones and ceiling effect gets smaller and you might not be able to see the effect of your treatment.
In your scenario which you have explained, sometimes you get EPSP and after some time you don't. This happen when a bubble comes near to your slice. Just aviod bubbles in your preparation, you will get very reproducible results.
I hope this help.Following
- Should the electrodes be placed within stratum radiatum or stratum moleculare (as both have Schaffer Collaterals) in CA1? I was also told that both the recording and stimulating electrode should be on the same Schaffer Collateral pathway (but there's no way to confirm for that visually when lowering the electrodes onto the slices isn't it?)